{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T08:01:03Z","timestamp":1793606463613,"version":"4.5.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,20]],"date-time":"2023-08-20T00:00:00Z","timestamp":1692489600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,20]],"date-time":"2023-08-20T00:00:00Z","timestamp":1692489600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Ethnic Research Initiative"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The risk factors for breast cancer have been defined in several studies but there is deficient data for specific subtypes. We report here the pathological characteristics of a breast cancer cohort and risk factors for patients with triple-negative disease. In this case\u2013control study, a prospective breast cancer cohort was evaluated for demographic, reproductive, obesity-related and other risk factors using a validated questionnaire. Tumors were characterized for routine pathological characteristics and immunohistochemical markers of basal-like breast cancer. Patients with triple-negative breast cancer (TNBC) constituted cases and those with non-TNBC were controls. Odds ratios (OR) were calculated for each risk factor and independent associations were tested in an unconditional logistic regression analysis. Between 2011 and 2014, 1146 patients were recruited, of whom 912 [TNBC 266 (29.1%), non-TNBC 646 (70.9%)] with sufficient pathology material were analysed. Reproductive factors of parity, breastfeeding, age-at-menarche, age at first full-term pregnancy and oral contraceptive use were not significantly associated with TNBC. Higher body mass index (BMI\u2009&gt;\u200924.9 vs\u2009\u2264\u200924.9, OR 0.89, 95%CI 0.63\u20131.24, p\u2009=\u20090.49) was not significantly associated while lesser waist circumference (&gt;\u200980\u00a0cm vs\u2009\u2264\u200980\u00a0cm, OR 0.64, 95%CI 0.45\u20130.9, p\u2009=\u20090.012) and lower waist-to-hip ratio were significantly associated (&gt;\u20090.85 vs\u2009\u2264\u20090.85, OR 0.72, 95%CI 0.51\u20131.0, p\u2009=\u20090.056), with TNBC. History of tobacco use was not significantly associated while lower socio-economic status was borderline associated with TNBC (socio-economic category\u2009&gt;\u20095 versus\u2009\u2264\u20095, OR 0.73, 95%CI 0.50\u20131.06, p\u2009=\u20090.106). No factor was significant after adjustment for covariates. Central obesity seems to be preferentially associated with non-TNBC, and lower socio-economic status with TNBC in India, while most other conventional risk factors of breast cancer show no significant association with TNBC versus non-TNBC.<\/jats:p>","DOI":"10.1038\/s41598-023-40443-8","type":"journal-article","created":{"date-parts":[[2023,8,20]],"date-time":"2023-08-20T16:01:37Z","timestamp":1692547297000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Risk factors for the development of triple-negative breast cancer versus non-triple-negative breast cancer: a case\u2013control study"],"prefix":"10.1038","volume":"13","author":[{"given":"Shona","family":"Nag","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh","family":"Dikshit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangeeta","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anupama","family":"Mane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharayu","family":"Mhatre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh","family":"Neve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamta","family":"Gurav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neelambari","family":"Bhosale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prema","family":"Perumal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yogesh","family":"Kembhavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinesh","family":"Jethwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajendra","family":"Badwe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudeep","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,20]]},"reference":[{"key":"40443_CR1","unstructured":"National Cancer Registry Programme: Consolidated report of the population based cancer registries 1990\u20131996. Supplement; Year-wise tabulation of incident cancers and rates by site and gender. (Indian Council of Medical Research, 2001)."},{"key":"40443_CR2","doi-asserted-by":"publisher","first-page":"47","DOI":"10.7314\/APJCP.2016.17.S3.47","volume":"17","author":"M Ghoncheh","year":"2016","unstructured":"Ghoncheh, M., Mahdavifar, N., Darvishi, E. & Salehiniya, H. Epidemiology, incidence and mortality of breast cancer in Asia. Asian Pac. J. Cancer Prev. 17, 47\u201352 (2016).","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"40443_CR3","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/BF00694745","volume":"35","author":"B Newman","year":"1995","unstructured":"Newman, B. et al. The Carolina Breast Cancer Study: Integrating population-based epidemiology and molecular biology. Breast Cancer Res. Treat. 35, 51\u201360 (1995).","journal-title":"Breast Cancer Res. Treat."},{"key":"40443_CR4","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1159\/000115288","volume":"3","author":"G Agarwal","year":"2008","unstructured":"Agarwal, G. & Ramakant, P. Breast cancer care in India: The current scenario and the challenges for the future. Breast Care 3, 21\u201327 (2008).","journal-title":"Breast Care"},{"key":"40443_CR5","doi-asserted-by":"publisher","first-page":"391","DOI":"10.4103\/0019-509X.92245","volume":"48","author":"J Ghosh","year":"2011","unstructured":"Ghosh, J. et al. Estrogen, progesterone and HER2 receptor expression in breast tumors of patients, and their usage of HER2-targeted therapy, in a tertiary care centre in India. Indian J. Cancer 48, 391\u2013396 (2011).","journal-title":"Indian J. Cancer"},{"key":"40443_CR6","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1200\/JGO.2016.005397","volume":"2","author":"GS Sandhu","year":"2016","unstructured":"Sandhu, G. S., Erqou, S., Patterson, H. & Mathew, A. Prevalence of triple-negative breast cancer in India: Systematic review and meta-analysis. J. Glob. Oncol. 2, 412\u2013421 (2016).","journal-title":"J. Glob. Oncol."},{"key":"40443_CR7","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1200\/GO.20.00054","volume":"6","author":"A Kulkarni","year":"2020","unstructured":"Kulkarni, A. et al. Meta-analysis of prevalence of triple-negative breast cancer and its clinical features at incidence in indian patients with breast cancer. JCO Glob. Oncol. 6, 1052\u20131062 (2020).","journal-title":"JCO Glob. Oncol."},{"key":"40443_CR8","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s10552-015-0697-y","volume":"27","author":"R Nagrani","year":"2016","unstructured":"Nagrani, R. et al. Understanding rural-urban differences in risk factors for breast cancer in an Indian population. Cancer Causes Control 27, 199\u2013208 (2016).","journal-title":"Cancer Causes Control"},{"key":"40443_CR9","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1093\/jnci\/dju237","volume":"106","author":"JR Palmer","year":"2014","unstructured":"Palmer, J. R. et al. Parity, lactation, and breast cancer subtypes in African American women: Results from the AMBER Consortium. J. Natl. Cancer Inst. 106, 237 (2014).","journal-title":"J. Natl. Cancer Inst."},{"key":"40443_CR10","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.ajpath.2017.09.018","volume":"188","author":"EC Dietze","year":"2018","unstructured":"Dietze, E. C., Chavez, T. A. & Seewaldt, V. L. Obesity and triple-negative breast cancer: Disparities, controversies, and biology. Am. J. Pathol. 188, 280\u2013290 (2018).","journal-title":"Am. J. Pathol."},{"key":"40443_CR11","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1186\/s40064-016-2200-y","volume":"5","author":"HL Chen","year":"2016","unstructured":"Chen, H. L., Ding, A. & Wang, M. L. Impact of central obesity on prognostic outcome of triple negative breast cancer in Chinese women. Springerplus 5, 594 (2016).","journal-title":"Springerplus"},{"key":"40443_CR12","doi-asserted-by":"publisher","first-page":"3319","DOI":"10.1158\/1055-9965.EPI-08-0544","volume":"17","author":"L Vona-Davis","year":"2008","unstructured":"Vona-Davis, L. et al. Triple-negative breast cancer and obesity in a rural Appalachian population. Cancer Epidemiol. Biomarkers Prev. 17, 3319\u20133324 (2008).","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"40443_CR13","doi-asserted-by":"publisher","first-page":"R18","DOI":"10.1186\/bcr2242","volume":"11","author":"LA Stead","year":"2009","unstructured":"Stead, L. A. et al. Triple-negative breast cancers are increased in black women regardless of age or body mass index. Breast Cancer Res. 11, R18 (2009).","journal-title":"Breast Cancer Res."},{"key":"40443_CR14","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/S0140-6736(08)60269-X","volume":"371","author":"AG Renehan","year":"2008","unstructured":"Renehan, A. G., Tyson, M., Egger, M., Heller, R. F. & Zwahlen, M. Body-mass index and incidence of cancer: A systematic review and meta-analysis of prospective observational studies. Lancet 371, 569\u2013578 (2008).","journal-title":"Lancet"},{"key":"40443_CR15","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1207\/S15327914NC4402_02","volume":"44","author":"BS Connolly","year":"2002","unstructured":"Connolly, B. S. et al. A meta-analysis of published literature on waist-to-hip ratio and risk of breast cancer. Nutr. Cancer. 44, 127\u2013138 (2002).","journal-title":"Nutr. Cancer."},{"key":"40443_CR16","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1046\/j.1467-789X.2003.00108.x","volume":"4","author":"M Harvie","year":"2003","unstructured":"Harvie, M., Hooper, L. & Howell, A. H. Central obesity and breast cancer risk: A systematic review. Obes. Rev. 4, 157\u2013173 (2003).","journal-title":"Obes. Rev."},{"key":"40443_CR17","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ejca.2016.07.022","volume":"66","author":"R Nagrani","year":"2016","unstructured":"Nagrani, R. et al. Central obesity increases risk of breast cancer irrespective of menopausal and hormonal receptor status in women of South Asian Ethnicity. Eur. J. Cancer. 66, 153\u2013161 (2016).","journal-title":"Eur. J. Cancer."},{"key":"40443_CR18","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/tbj.12828","volume":"24","author":"T Pai","year":"2018","unstructured":"Pai, T. et al. Evidence for the association of Epstein\u2013Barr Virus in breast cancer in Indian patients using in-situ hybridization technique. Breast J. 24, 16\u201322 (2018).","journal-title":"Breast J."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-40443-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-40443-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-40443-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T14:10:21Z","timestamp":1700403021000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-40443-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,20]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["40443"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-40443-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,20]]},"assertion":[{"value":"26 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr. Shona Nag has received previous research funding from Roche. She has also received honorarium from AstraZeneca, Pfizer, Dr. Reddy\u2019s, Intas, Novartis, Lupin Pharmaceuticals and Roche. Dr. Sudeep Gupta has received research funding support to his institution from GSK, Roche, Eisai, Zydus, Intas, Novartis and AstraZeneca. Dr. Rajesh Dikshit, Dr. Sangeeta Desai, Dr. Anupama Mane, Dr. Sharayu Mhatre, Dr. Rakesh Neve, Ms. Mamta Gurav, Ms. Neelambari Bhosale, Ms. Prema Perumal, Mr. Yogesh Kembhavi, Mr. Dinesh Jethwa, and Dr. Rajendra Badwe declare no potential conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13551"}}